Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margalida Calafat

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Postgraduate Medical Journal|June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA projectCarlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Therapeutic Advances in Gastroenterology|March 6, 2024
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Digestive Diseases (Basel, Switzerland)|March 7, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA RegistryIván Guerra, Francisco Barros, María Chaparro, et al.
Journal of Crohn'S & Colitis|July 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA RegistryMaría José García, Montserrat Rivero, Agnès Fernández-Clotet, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Journal of Crohn'S & Colitis|February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCUManuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
The American Journal of Gastroenterology|December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCUManuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis|August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA RegistryDiego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Postgraduate Medical Journal|June 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA projectCarlos González-Muñoza, Margalida Calafat, Javier P Gisbert, et al.
Therapeutic Advances in Gastroenterology|March 6, 2024
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Digestive Diseases (Basel, Switzerland)|March 7, 2024
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA RegistryIván Guerra, Francisco Barros, María Chaparro, et al.
Journal of Crohn'S & Colitis|July 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA RegistryMaría José García, Montserrat Rivero, Agnès Fernández-Clotet, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Journal of Crohn'S & Colitis|February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCUManuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
The American Journal of Gastroenterology|December 14, 2022
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCUManuel Barreiro-de Acosta, Agnès Fernández-Clotet, Francisco Mesonero, et al.
Journal of Crohn'S & Colitis|August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA RegistryDiego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
Gastroenterologia Y Hepatologia|May 6, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohortCristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, et al.
Pageof 7